DB Schenker, Cargolux to start Indianapolis charter for pharma shipments; launches DB SCHENKERlife+
DB Schenker and Cargolux announce a new full charter cargo connection between Luxembourg and Indianapolis, US, starting in January 2021.
December 24, 2020: DB Schenker and Cargolux announce a new full charter cargo connection between Luxembourg and Indianapolis, US, starting in January 2021. With this new agreement both partners expand their well-established 15 year-long partnership. Cargolux's initial service between its home base in Luxembourg and the Indiana capital was inaugurated in 2005 to support DB Schenker's business in the region.
With weekly departures on a B747 freighter DB Schenker makes Cargolux's extensive experience in the handling of pharmaceutical and healthcare goods available for its customers in Europe and Northern America. By partnering with the leading provider of transportation services for pharmaceutical and healthcare products and the airline that was, in 2014, the first to be GDP certified, DB Schenker reaches a milestone in setting up its new healthcare service portfolio DB SCHENKERlife .
Veronique Dameme, head of global vertical market healthcare at DB Schenker, said, "Our new product portfolio DB SCHENKERlife offers exceptional quality, unconditional security and fully reliable logistics services. The cooperation with Cargolux expands the foundation for our robust global GDP programme and customised services as air track, 24x7 monitoring, packaging supplies or telemetric devices. In such volatile times, DB SCHENKERlife thus provides urgently needed transparency and predictability."
"Cargolux is pleased to launch this new weekly charter service in collaboration with DB Schenker. Both companies have enjoyed a fruitful and mutually beneficial partnership on this lane over the past 15 years and we are happy to expand on this success," said Domenico Ceci, Cargolux's executive vice president sales and marketing.
The new weekly connection between Luxembourg and Indianapolis makes DB Schenker's portfolio of customisable services available in the world's regions with the highest demand for healthcare and pharmaceutical products and creates capacities for potential Covid-19 vaccine transportation demand.